M
498.04
1.07 (0.22%)
| Penutupan Terdahulu | 496.97 |
| Buka | 496.97 |
| Jumlah Dagangan | 213,542 |
| Purata Dagangan (3B) | 359,371 |
| Modal Pasaran | 11,311,196,160 |
| Harga / Jualan (P/S) | 14.85 |
| Harga / Buku (P/B) | 18.00 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2025 |
| Margin Keuntungan | -123.38% |
| Margin Operasi (TTM) | -57.79% |
| EPS Cair (TTM) | -17.83 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 16.85% |
| Nisbah Semasa (MRQ) | 5.91 |
| Aliran Tunai Operasi (OCF TTM) | -395.31 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -274.11 M |
| Pulangan Atas Aset (ROA TTM) | -25.56% |
| Pulangan Atas Ekuiti (ROE TTM) | -50.16% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Madrigal Pharmaceuticals, Inc. | Menaik | Menaik |
AISkor Stockmoo
-0.7
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.70 |
|
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 7.73% |
| % Dimiliki oleh Institusi | 108.28% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Paulson & Co. Inc. | 30 Sep 2025 | 1,907,523 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 900.00 (Piper Sandler, 80.71%) | Beli |
| Median | 645.00 (29.51%) | |
| Rendah | 445.00 (B of A Securities, -10.65%) | Pegang |
| Purata | 657.13 (31.94%) | |
| Jumlah | 7 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 530.03 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citizens | 20 Jan 2026 | 745.00 (49.59%) | Beli | 504.95 |
| 05 Nov 2025 | 527.00 (5.81%) | Beli | 475.87 | |
| Piper Sandler | 19 Dec 2025 | 900.00 (80.71%) | Beli | 591.02 |
| B. Riley Securities | 11 Dec 2025 | 670.00 (34.53%) | Beli | 571.33 |
| HC Wainwright & Co. | 21 Nov 2025 | 620.00 (24.49%) | Beli | 547.96 |
| 11 Nov 2025 | 568.00 (14.05%) | Beli | 541.50 | |
| Oppenheimer | 20 Nov 2025 | 650.00 (30.51%) | Beli | 542.12 |
| Truist Securities | 19 Nov 2025 | 640.00 (28.50%) | Beli | 555.60 |
| Canaccord Genuity | 13 Nov 2025 | 587.00 (17.86%) | Beli | 514.93 |
| B of A Securities | 03 Nov 2025 | 445.00 (-10.65%) | Pegang | 412.35 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| KELLEY SHANNON T | - | 504.95 | -692 | -349,425 |
| TAUB REBECCA | - | 504.95 | -2,238 | -1,130,078 |
| THAKKAR RITA | 495.88 | - | 2,398 | 1,189,120 |
| Jumlah Keseluruhan Kuantiti Bersih | -532 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -290,383 | |||
| Purata Pembelian Keseluruhan ($) | 495.88 | |||
| Purata Jualan Keseluruhan ($) | 504.95 | |||
| Julat Insider ($) | ||||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| TAUB REBECCA | Pengarah | 20 Jan 2026 | Jual (-) | 2,238 | 504.95 | 1,130,078 |
| KELLEY SHANNON T | Pegawai | 20 Jan 2026 | Jual (-) | 263 | 504.95 | 132,802 |
| KELLEY SHANNON T | Pegawai | 20 Jan 2026 | Jual automatik (-) | 429 | 504.95 | 216,624 |
| THAKKAR RITA | Pegawai | 15 Jan 2026 | Diperolehi (+) | 2,398 | 495.88 | 1,189,120 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |